[PDF] Top 20 Estudio sobre el sistema de almacenamiento de agua caliente sanitaria en un sistema solar térmico

... of sirolimus cobalt chromium stent and sirolimus stainless steel stent in patients suffering from ...(cobalt chromium and stainless ... See full document

... BMS stent had shown favourable clinical performance at 2 years mean ...is comparative with earlier study of various BMS stent-like Bard XT [(Bard Ireland, Galway, Ireland) - balloon-expandable ... See full document

... its stent platform which is coated with a biodegradable polymer to deliver ...® stent system proved its effectiveness by reducing restenosis at 8 months and safety with an acceptable rate of cardiac events ... See full document

... To test the primary hypothesis (non-inferiority of the Orsiro SES relative to the ZES-I by 9-month in-stent late lumen loss), we assumed a mean late loss of 0.3 mm (SD 0.54 mm) for both stents, which was ... See full document

... of stent area between FD-OCT and histology was ...and stent area were greater than the same histological measure- ments in the study, and similar result was also reported by Murata A et al ...in- ... See full document

... percutaneous coronary intervention (PCI) was performed with implanta- tion of a BMS or DES at the Department of Medicine III, Martin Luther-University Halle-Wittenberg between 2004 and 2006 were retrospectively ... See full document

... LMCA disease who underwent stenting (BMS, 318 and DES, 784) or CABG (1,138) at 12 major cardiac centers in Korea, where left-main stenting is far more common than in Western ... See full document

... the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions: A randomized comparison of a sirolimus eluting ... See full document

... the stent and drug retention during its insertion and ...the stent dictate the kinetics of drug release over a period of weeks to months following ...by stent coatings composed of synthetic ... See full document

... minimum stent diameter divided by maximum stent ...entire stent (Fig. 1C). For the evaluation of the association between different SE parame- ters of each DES and angiographic or clinical ... See full document

... multi-vessel disease has traditionally included target vessel revascularisation, the importance of this end-point has recently been ...main disease does not include TVR in its composite primary ... See full document

... TVR between patients treated with BP-DESs and pa- tients treated with DP-DESs. However, the occurrence of very late ST (>12 months) may be significantly reduced by the use of BP-DESs instead of DP-DESs, and the gen- ... See full document

... One study limitation was the exclusion of HCRU in patients who did not survive the index hospitalisation, as only patients discharged alive were included. It should be noted, however, that survivors of ACS represent a ... See full document

... the coronary artery [28] and that higher dose of polymer coat causes more severe strut-associated inflammation indicat- ing a possible bulk effect ... See full document

... infarction, coronary artery bypass grafting (CABG), stroke, vascular access complications, renal insufficiency, allergy and stroke/TIA ...of stent thrombosis of up to 1% with significant mortality ... See full document

... the patient population was highly selected, there was very low rate of DES utilization, and a high crossover rate from medi- cal therapy to PCI was permitted which weakens conclusions regarding late ... See full document

... interventional coronary rotational atherectomy on the correlation be- tween serum inflammatory factors and plaque stability indexes in patients with coronary artery disease ...and ... See full document

... continued at least 3 months after the procedure. From May to October, 2011, in 98 Japanese centers, 3,235 patients were randomized 1:1 without any exclusion criteria to undergo PCI with either the BES or the EES. ... See full document

... We urge caution in interpreting these findings because randomized studies have not shown a mortality benefit (22-24). With regard to the efficacy of DES among diabetic patients, we found that future TVR was reduced by ... See full document

... polymer-coated sirolimus-eluting coronary stent (SES) system for the treatment of coronary artery disease (CAD) has been implanted in a real-world patient ...Metafor™ ... See full document